In this study, we sequenced 191 BCC lesions and 115 corresponding normal skin surrounding tumors for mutations in the PTCH1 and TP53 genes, and the TERT and DPH3 promoters. The gene discussed is TP53; the disease is skin basal cell carcinoma.